Biogen (BIIB) Announces FDA Grants Accelerated Approval for QALSODY for SOD1-ALS

Go back to Biogen (BIIB) Announces FDA Grants Accelerated Approval for QALSODY for SOD1-ALS
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 215.50 --0 (-0%)
Previous Close $215.50    52 Week High $333.65 
Open $215.50    52 Week Low $223.02 
Day High $215.50    P/E 27.59 
Day Low $215.50    EPS $7.81 
Volume 1,049